Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Neomycin, Polymyxin B Sulphate and Bacitracin Zinc
Trade Name
Risk Category
  • Studies on animals show adverse effect and toxicity on fetus.
  • No adequate and well controlled studies done on pregnant women.
  • Drugs should be given only if the potential benefit outweighs the potential risk to the fetus.
The risk category is B for Polymyxin.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

  • Local treatment of inflammatory skin disorders.
  • Fetal Risk
    Fetal Risk
  • No adequate data for neomycin, but eight cranial nerve toxicity in the fetus an occur following exposure to other aminoglycoside (as kanamycin and streptomycin) and could potentially occur with neomycin.
  • Limited data for bacitracin and polymixin B in pregnancy, but no association with congenital malformations has been reported in 1st trimester exposure.
  • Breast Feeding
    Breast Feeding
  • No data available for bacitracin and polymyxin B and neomycin in breast feeding.
  • Other Trade Names
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        Your Friend
     5   +   5    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Month Day Year